SABSW
USDSAB Biotherapeutics Inc. Warrant
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$0.048
High
$0.039
Low
$0.028
Volume
0.01M
Company Fundamentals
Industry
Biotechnology
Country
United States
Trading Stats
Exchange
NCM
Currency
USD
52-Week Range
Related News
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other
SAB BIO to Participate in Upcoming Investor Conferences
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its
Related Stocks
SABA
Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
MLI
Mueller Industries Inc.
GJS
Goldman Sachs Group Securities STRATS Trust for Goldman Sachs Group Securities Series 2006-2
CAL
Caleres Inc.
SPFI
South Plains Financial Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.